Expression of the costimulatory molecule BB-1, the ligands CTLA-4 and CD28, and their mRNA in inflammatory myopathies.
about
Treatment of inflammatory myopathy: emerging therapies and therapeutic targetsInflammation induced loss of skeletal muscleImmune and myodegenerative pathomechanisms in inclusion body myositisStem cell transplantation for muscular dystrophy: the challenge of immune response.Immunological tolerance to muscle autoantigens involves peripheral deletion of autoreactive CD8+ T cellsImmunological capabilities of skeletal muscle cells.Results and long-term followup of intravenous immunoglobulin infusions in chronic, refractory polymyositis: an open study with thirty-five adult patients.Sporadic inclusion body myositis--diagnosis, pathogenesis and therapeutic strategies.Proteasome inhibition and aggresome formation in sporadic inclusion-body myositis and in amyloid-beta precursor protein-overexpressing cultured human muscle fibersExpression of ErbB4 in the neurons of Alzheimer's disease brain and APP/PS1 mice, a model of Alzheimer's diseasePathogenesis of idiopathic inflammatory myopathies.Mechanisms of disease: signaling pathways and immunobiology of inflammatory myopathies.Immune mechanisms in the pathogenesis of idiopathic inflammatory myopathies.Advances in the immunobiology and treatment of inflammatory myopathies.Modern Therapies for Idiopathic Inflammatory Myopathies (IIMs): Role of Biologics.Immunopathogenesis of juvenile dermatomyositis.Review: An update on inflammatory and autoimmune myopathies.Targeted immunotherapy trials for idiopathic inflammatory myopathies.Inclusion body myositis: from immunopathology and degenerative mechanisms to treatment perspectives.Abatacept as a successful therapy for myositis—a case-based review.Current pharmacological treatment of idiopathic inflammatory myopathies.Update on the pharmacological treatment of adult myositis.The non-classical MHC molecule HLA-G protects human muscle cells from immune-mediated lysis: implications for myoblast transplantation and gene therapy.Expression of ErbB4 in the apoptotic neurons of Alzheimer's disease brain.Cross-reactive cytotoxic T lymphocytes against human immunodeficiency virus type 1 protease and gamma interferon-inducible protein 30.Calpain inhibitor-1 protects the rat heart from ischemia-reperfusion injury: analysis by mechanical work and energetics.Na+/Ca2+ exchange inhibition protects the rat heart from ischemia-reperfusion injury by blocking energy-wasting processes.Inclusion body myositis with human immunodeficiency virus infection: four cases with clonal expansion of viral-specific T cells.Detrimental effects after dobutamine infusion on rat left ventricular function: mechanical work and energetics.Calpain-dependent alpha-fodrin cleavage at the sarcolemma in muscle diseases.Inclusion body myositis: clonal expansions of muscle-infiltrating T cells persist over time.
P2860
Q26796546-F189CEB4-5331-447D-B978-6E65036A3E6EQ28083759-4CE19CE5-6DFC-4344-A3A2-5CA6EDD901AFQ33753870-FD69CD3F-B16C-45DE-9CE5-501411A0D5FFQ33902416-611F594B-BB76-41AC-A2E9-3BFADCB1EBB8Q34263314-908E65C0-1C47-4827-B476-D767EFB67ACCQ34285772-F6018BF4-1782-4F23-8214-CB5ADC9CEC81Q34521023-B72841BA-79A5-4F67-A5DB-12AD2317E417Q34560528-74D2AC36-22DF-4F98-AD65-D217BD3BDFD2Q35085041-AACAB478-8E5F-4EBD-932D-ED6518999DC0Q35134520-791ECE6C-2DC3-4EF9-8A89-35B4E4C73B2AQ36562010-B16CE448-F937-493D-B0AE-F857BD4A0902Q36577472-D06F57E5-C0FD-45D7-803A-4B7402CEC75FQ36771917-5AD20CAB-F485-4EA0-B70C-1CE1ECD9202AQ36905991-F681E6EA-E65D-43D1-B893-6055527569F8Q37095730-4DCE4D91-D56B-43AC-8963-1E257AC90537Q37734332-6185691B-A066-4309-B3C5-FC6A623E4CE4Q37820692-C0372B6E-9B00-46CA-92F4-2719CCA185AEQ38023207-252E80EB-E58B-43CD-BC39-06D687CBBA0FQ38153797-F9604F66-ED71-48C1-B74E-C67D39B145B4Q38184953-ACCABAD4-52CE-4FE2-9D58-A926A7463ED5Q38680762-4DCFC0FA-F3B1-4D2A-A775-46F815728506Q38813275-7DD8FDBC-09F8-4706-B8A9-91357262FBC3Q40616181-8F869841-6936-46F3-9E7D-87103F7FC38BQ42077740-9480CC60-B68F-47A9-A15F-A831F13DA1F8Q42723080-AD9F47D9-D333-40B8-9CFA-45CD72C4985AQ45140523-F157B67E-983C-4274-BBB3-B4CB8C0B8A28Q45207392-DC4DCB16-6207-4012-8E53-D7B087B9631FQ45406126-66CF4771-E4F0-4C2A-A2A0-99A60CB0EB6BQ46453499-5D051617-3335-4D84-9D5C-7212547084DAQ52047477-B2842619-974A-40F7-8AB7-D01E27C19CA4Q54764251-D00FD032-AD48-4C14-83E4-114E1BBB8F51
P2860
Expression of the costimulatory molecule BB-1, the ligands CTLA-4 and CD28, and their mRNA in inflammatory myopathies.
description
1999 nî lūn-bûn
@nan
1999年の論文
@ja
1999年論文
@yue
1999年論文
@zh-hant
1999年論文
@zh-hk
1999年論文
@zh-mo
1999年論文
@zh-tw
1999年论文
@wuu
1999年论文
@zh
1999年论文
@zh-cn
name
Expression of the costimulator ...... NA in inflammatory myopathies.
@ast
Expression of the costimulator ...... NA in inflammatory myopathies.
@en
type
label
Expression of the costimulator ...... NA in inflammatory myopathies.
@ast
Expression of the costimulator ...... NA in inflammatory myopathies.
@en
prefLabel
Expression of the costimulator ...... NA in inflammatory myopathies.
@ast
Expression of the costimulator ...... NA in inflammatory myopathies.
@en
P2860
P1476
Expression of the costimulator ...... NA in inflammatory myopathies.
@en
P2093
P2860
P304
P356
10.1016/S0002-9440(10)65141-3
P407
P577
1999-08-01T00:00:00Z